7269 Suzuki Motor

Watchlist

1775.0
-19.5-1.09%

20min DelayNot Open Dec 16 15:30 JST

3.49TMarket Cap12.83P/E (Static)

Suzuki Motor Key Stats

According to the latest financial report of Suzuki Motor, the latest earnings per share (TTM) for the company is 59.21. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: JPY

Quarterly

FCF

Interested in knowing about Suzuki Motor's free cash flow? The latest report shows it as 76.20B. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: JPY

Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Suzuki Motor shows that the company's current ratio is 1.61, indicating healthy liquidity.

Currency: JPY

Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Suzuki Motor, the quick ratio is 1.11, indicating that the company can meet its short-term debt obligations.

Currency: JPY

Quarterly

ROE

Want to learn more about the financial health of Suzuki Motor? The latest ROE figure is 4.24%, indicating that the company has stable profitability.

Currency: JPY

Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Suzuki Motor, the total asset return on investment (ROA) is 2.02%.

Currency: JPY

Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Suzuki Motor's latest financial report to see how their gross margin is doing - currently at 27.38%.

Currency: JPY

Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Suzuki Motor, the net profit margin is 9.74%, which is a good sign for its profitability.

Currency: JPY

Quarterly

Symbol Price % Chg

D. Western Therapeutics Institute

4576